The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 25, 2020
Filed:
Apr. 02, 2018
Applicants:
Allergan, Inc., Irvine, CA (US);
Xencor, Inc., Monrovia, CA (US);
Inventors:
Peter C. Baciu, Laguna Niguel, CA (US);
Yanbin Liang, Irvine, CA (US);
Jason Guu, Yorba Linda, CA (US);
Matthew Bernett, Monrovia, CA (US);
Umesh Muchhal, Monrovia, CA (US);
John Desjarlais, Monrovia, CA (US);
Assignees:
ALLERGAN, INC., Irvine, CA (US);
XENCOR, INC., Monrovia, CA (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 39/00 (2013.01); A61K 39/0005 (2013.01); A61K 39/3955 (2013.01); C07K 2317/24 (2013.01); C07K 2317/76 (2013.01);
Abstract
The present disclosure relates to antibodies and polynucleotides encoding the same, that may be used to prevent, control, or reduce the activity of the complement pathway. In addition, the disclosure is directed to compositions and methods for diagnosing and treating diseases mediated by or involving complement C5. Specifically, the disclosure is related to C5 antibodies.